featured
Effect of CRP on Lp(a)-Associated Cardiovascular Risk in Optimally Treated Patients With High-Risk Vascular Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA Cardiology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effect of C-Reactive Protein on Lipoprotein(a)-Associated Cardiovascular Risk in Optimally Treated Patients With High-Risk Vascular Disease: A Prespecified Secondary Analysis of the ACCELERATE Trial
JAMA Cardiol 2020 Jul 08;[EPub Ahead of Print], R Puri, SE Nissen, BJ Arsenault, J St John, JS Riesmeyer, G Ruotolo, E McErlean, V Menon, L Cho, K Wolski, AM Lincoff, SJ NichollsFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.